$ACB
AURORA CANNABIS INC
CIK:0001683541|SEC Filings
Consolidated Statements of Cash Flows - CAD ($) $ in Thousands |
12 Months Ended | ||||
|---|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
||||
| Operating activities | |||||
| Net income (loss) from continuing operations | $ (58,619) | $ 27,050 | [1] | ||
| Adjustments for non-cash items: | |||||
| Unrealized gain on changes in fair value of biological assets | (116,131) | (168,111) | [1] | ||
| Changes in fair value of inventory and biological assets sold | 138,255 | 131,985 | [1] | ||
| Depreciation of property, plant and equipment | 13,384 | 12,289 | [1] | ||
| Amortization of intangible assets | 808 | 315 | [1] | ||
| Share-based compensation | 7,293 | 11,524 | [1] | ||
| Impairment of property, plant and equipment | 2,775 | 696 | [1] | ||
| Impairment of intangible assets and goodwill | 13,186 | 0 | [1] | ||
| Net interest accrual and accretion | (1,147) | 1,355 | [1] | ||
| Deferred tax recovery (expense) | 55 | (3,152) | [1] | ||
| Other gains (losses) | (720) | (1,463) | [1] | ||
| Foreign exchange gain (loss) | (1,558) | (11,529) | [1] | ||
| Deferred compensation amortization | 3,805 | 3,805 | [1] | ||
| Cash provided by (used in) operating activities from continuing operations before changes in non-cash working capital | 1,386 | 4,764 | [1] | ||
| Changes in non-cash working capital | (9,214) | 14,205 | [1] | ||
| Net cash provided by (used in) operating activities from continuing operations | (7,828) | 18,969 | [1] | ||
| Net cash used in operating activities from discontinued operations | (5,683) | (2,963) | [1] | ||
| Net cash provided by (used in) operating activities | (13,511) | 16,006 | [1] | ||
| Investing activities | |||||
| Purchase of short-term investments | (52,213) | 0 | [1] | ||
| Proceeds from disposal of marketable securities | 0 | 5,488 | [1] | ||
| Purchase of property, plant and equipment and intangible assets | (22,545) | (15,054) | [1] | ||
| Proceeds from disposal of property, plant and equipment and assets held for sale | 1,096 | 1,981 | [1] | ||
| Changes in restricted cash | 818 | (4,283) | [1] | ||
| Cash provided by (used in) investing activities from continuing operations | (72,844) | (11,868) | [1] | ||
| Net cash provided by (used in) investing activities from discontinued operations | 235 | (2,460) | [1] | ||
| Net cash provided by (used in) investing activities | (72,609) | (14,328) | [1] | ||
| Financing activities | |||||
| Net principal payments of lease liabilities | (5,019) | (5,240) | [1] | ||
| Proceeds from issuance of shares | 10,906 | 0 | [1] | ||
| Share issuance costs | (1,578) | 0 | [1] | ||
| Proceeds from stock option exercise | 587 | 820 | [1] | ||
| Cash provided by (used in) financing activities from continuing operations | 4,896 | (4,420) | [1] | ||
| Net cash provided by (used in) financing activities from discontinued operations | 4,865 | 4,304 | [1] | ||
| Net cash provided by (used in) financing activities | 9,761 | (116) | [1] | ||
| Effect of foreign exchange on cash and cash equivalents | 3,128 | 264 | [1] | ||
| Increase (decrease) in cash and cash equivalents | (73,231) | 1,826 | [1] | ||
| Cash and cash equivalents, beginning of period | [1] | 137,921 | 136,095 | ||
| Cash and cash equivalents, end of period | $ 64,690 | $ 137,921 | [1] | ||
| |||||
Consolidated Statements of Financial Position - CAD ($) $ in Thousands |
Mar. 31, 2026 |
Mar. 31, 2025 |
|||
|---|---|---|---|---|---|
| Current assets | |||||
| Cash and cash equivalents | $ 64,690 | $ 137,921 | [1] | ||
| Restricted cash | 47,791 | 47,407 | |||
| Short-term investments | 52,213 | 0 | |||
| Accounts receivable | 44,578 | 42,470 | |||
| Biological assets | 20,213 | 51,168 | |||
| Inventory | 154,862 | 187,925 | |||
| Prepaids and other current assets | 11,120 | 11,215 | |||
| Assets held for sale | 1,986 | 222 | |||
| Current assets | 397,453 | 478,328 | |||
| Property, plant and equipment | 123,688 | 268,107 | |||
| Long-term investments | 12,113 | 0 | |||
| Deposits and other long-term assets | 3,618 | 7,722 | |||
| Lease receivable | 3,665 | 5,256 | |||
| Intangible assets | 31,441 | 45,163 | |||
| Goodwill | 26,651 | 43,871 | |||
| Deferred tax assets | 2,458 | 4,219 | |||
| Total assets | 601,087 | 852,666 | |||
| Current liabilities | |||||
| Accounts payable and accrued liabilities | 50,592 | 73,605 | |||
| Income taxes payable | 6,959 | 7,601 | |||
| Deferred revenue | 1,270 | 1,074 | |||
| Loans and borrowings - current portion | 0 | 21,513 | |||
| Lease liabilities - current portion | 5,729 | 5,381 | |||
| Provisions | 2,380 | 1,689 | |||
| Current liabilities | 66,930 | 110,863 | |||
| Loans and borrowings | 0 | 40,194 | |||
| Lease liabilities | 18,130 | 37,495 | |||
| Derivative liabilities | 3,697 | 5,531 | |||
| Other long-term liabilities | 498 | 48,095 | |||
| Deferred tax liabilities | 0 | 1,897 | |||
| Total liabilities | 89,255 | 244,075 | |||
| Shareholders’ equity | |||||
| Share capital | 7,007,226 | 6,991,154 | |||
| Contributed surplus | 160,108 | 158,970 | |||
| Accumulated other comprehensive loss | (213,594) | (215,208) | |||
| Retained earnings (deficit) | (6,441,908) | (6,367,745) | |||
| Equity attributable to Aurora Cannabis Inc. shareholders | 511,832 | 567,171 | |||
| Non-controlling interests | 0 | 41,420 | |||
| Total shareholders’ equity | 511,832 | 608,591 | |||
| Total liabilities and shareholders’ equity | $ 601,087 | $ 852,666 | |||
| |||||